TCBIO Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
About Texas Capital Bancshares, Inc. - Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B Company overview from Wikipedia
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
Read more
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
History
The bank was established on December 18, 1998, by a group of entrepreneurial bankers who were able to raise $80 million in start-up capital, the most for a new financial institution at that time. In 2003, the company completed an IPO. The online-only subsidiary Bask Bank was launched in early 2020.
In 2020, a potential merger with Independent Bank Group of McKinney, Texas collapsed, causing the CEO to step down. In late 2021, the new CEO adopted a strategy of moving away from loan-oriented growth in the commercial banking sector, towards becoming a full-service financial institution over the following five years, and launched a new investment bank division.
On September 6, 2022, it was announced that Texas Capital Bancshares would sell BankDirect Capital Finance, a premium financing company founded in 2005, to Truist Financial for $3.4 billion. The sale was part of its strategic shift, allowing it to shed a non-core business while increasing its capital levels during the transition.
In March 2022, Texas Capital Bank was named by Newsweek Magazine as the most trustworthy bank in America, based on a survey of 50,000 U.S. residents. In October 2022, it expanded its lease at 2000 McKinney Avenue in Uptown Dallas for its headquarters, and the building was renamed Texas Capital Center. Texas Capital Bancshares received investments from several hedge funds in late 2022.
Services
The bank primarily serves clients and operates full-service locations in Austin, Dallas, Fort Worth, Houston, and San Antonio metropolitan areas of Texas. It also has an executive office in New York. As of March 2023, the company held $28.4 billion in assets and had around 2,200 employees.
The bank offers many business deposit products and services, as well as other treasury management services and consumer deposit products. The company also provides commercial loans and financing for corporate purposes, and personal wealth management and trust services. It also has an online-only banking division, Bask Bank, with perks focusing on frequent airline fliers. It operates a nonprofit arm called Texas Capital Bank Foundation.
Controversy
In Late 2020, Texas Capital Bank's stock price rose 93% on consolidation by Bill Hwang's Archegos fund. Archegos' full position amounted to a more than 20% stake in Texas Capital Bank, at its peak. During this time, Archegos was in communication with Texas Capital management about its rising stake, including with Jody Grant, who founded the Bank in 1998. Grant's discussions with Hwang's family office were friendly, and it appears Archegos were supportive of Texas Capital Bank's management.
As the stock price rose towards a two-year high around March 2021, Texas Capital decided to issue 12,000,000 new shares for an aggregate sum of $300 million. Morgan Stanley participated in leading the book building process for the offering, even as Morgan Stanley was also involved in offering Archegos' prime brokerage service and holding Texas Capital's shares for Archegos in that capacity.
In the weeks after Texas Capital's fundraising the company's market value briefly touched US$4.5 billion. Subsequently, Archegos imploded and executives of the fund were charged with fraud.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
TCBIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
TCBIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| June 1, 2026 | $0.3590 |
| March 2, 2026 | $0.3590 |
| Dec. 1, 2025 | $0.3590 |
| Sept. 2, 2025 | $0.3590 |
| June 2, 2025 | $0.3590 |
| March 3, 2025 | $0.3590 |
| Dec. 2, 2024 | $0.3590 |
| Sept. 3, 2024 | $0.3590 |
| June 3, 2024 | $0.3590 |
| Feb. 29, 2024 | $0.3590 |
| Nov. 30, 2023 | $0.3590 |
| Aug. 31, 2023 | $0.3590 |
| May 31, 2023 | $0.3590 |
| Feb. 28, 2023 | $0.3590 |
| Nov. 30, 2022 | $0.3590 |
| Aug. 31, 2022 | $0.3590 |
| May 31, 2022 | $0.3590 |
| Feb. 28, 2022 | $0.3590 |
| Nov. 30, 2021 | $0.3590 |
| Aug. 31, 2021 | $0.3590 |
TCBIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 4 21.1%
- Buy 5 26.3%
- Hold 8 42.1%
- Sell 2 10.5%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $1.83 | $1.90 | -0.07% |
| March 31, 2026 | $1.56 | $1.43 | 0.13% |
| Dec. 31, 2025 | $2.12 | $1.80 | 0.32% |
| Sept. 30, 2025 | $2.18 | $1.81 | 0.37% |
| June 30, 2025 | $1.58 | $1.31 | 0.27% |
| March 31, 2025 | $0.92 | $0.99 | -0.07% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TCBIO | — | — | — | — | — | — |
| SFBS | $3.92B | 14.2 | 16.8% | 49.2% | 16.0% | — |
| TFSL | $3.70B | 41.2 | 6.0% | 28.3% | 4.8% | — |
| FULT | — | — | — | — | — | — |
| IBOC | — | 10.0 | 1.0% | 49.0% | 13.1% | — |
| UCB | $3.77B | 11.9 | 11.7% | 30.9% | 9.0% | — |
| TCBI | $4.69B | 13.3 | 34.7% | 26.3% | 9.2% | — |
| CATY | $3.25B | 10.7 | 2.9% | 585.8% | 10.8% | — |
| WSFS | $4.22B | 10.9 | — | 27.0% | 10.8% | — |
| CVBF | $2.52B | 12.2 | 2.7% | 40.6% | 9.2% | — |
| INDB | $3.60B | 16.5 | 24.3% | 23.9% | 6.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 8
| Metric | Trend | Q2 2026 |
|---|---|---|
| Interest Income | $440M | |
| Pretax Income | $112M | |
| Income Tax | $27M | |
| Net Income | $85M | |
| EPS (Basic) | $1.85 | |
| EPS (Diluted) | $1.83 | |
| Shares (Basic) | 43,599,022 | |
| Shares (Diluted) | 44,062,419 |
Balance Sheet 12
| Metric | Trend | Q2 2026 |
|---|---|---|
| PP&E (Net) | $92M | |
| Total Assets | $33.91B | |
| Total Liabilities | $30.27B | |
| Long-term Debt | $501M | |
| Common Stock | $520.0K | |
| Paid-in Capital | $1.08B | |
| Retained Earnings | $2.95B | |
| Treasury Stock | $586M | |
| AOCI | $-99M | |
| Stockholders' Equity | $3.65B | |
| Liabilities + Equity | $33.91B | |
| Shares Outstanding | 52,012,706 |
Cash Flow 9
| Metric | Trend | Q2 2026 |
|---|---|---|
| D&A | $16M | |
| Stock-based Comp | $10M | |
| Operating Cash Flow | $103M | |
| CapEx | $10M | |
| Investing Cash Flow | $305M | |
| Debt Issued | $-84.0K | |
| Stock Repurchased | $24M | |
| Financing Cash Flow | $333M | |
| Taxes Paid | $66M |
Profitability 4
| Metric | Trend | Q2 2026 |
|---|---|---|
| Net Margin | 25.3% | |
| Pretax Margin | 33.4% | |
| ROA | 0.26% | |
| ROE | 2.4% |
Efficiency 1
| Metric | Trend | Q2 2026 |
|---|---|---|
| Asset Turnover | 0.0 |
Valuation (TTM) 6
| Metric | Trend | Q2 2026 |
|---|---|---|
| Net Income TTM | $341M | |
| Market Cap | $1.06B | |
| P/E | 2.9 | |
| P/B | 0.3 | |
| P / Tangible Book | 0.3 | |
| Earnings Yield | 35.0% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Company insiders 5 insiders · 5 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Rob C Holmes | Chairman, President and CEO | June 5, 2026 S | 167,635 | 0 | 1 | $-5,002,308 |
| John Matthew Scurlock | Chief Financial Officer | June 15, 2026 P | 22,279 | 1 | 0 | $4,457 |
| Ellen Detrich | Controller | July 24, 2026 S | 7,529 | 0 | 1 | $-204,561 |
| David W Oman | Chief Risk Officer | July 1, 2026 M | 3,779 | 0 | 0 | $0 |
| Anna M Alvarado | Chief Legal Officer | June 9, 2026 S | 23,810 | 0 | 1 | $-353,325 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Sandler O’Neill Asset Management, LLC, SOAM Holdings, LLC, Malta Partners, L.P., Malta Hedge Fund, L.P., Malta Hedge Fund II, L.P., Malta Offshore, Ltd, Malta MLC Fund, LP, Malta MLC Offshore, Ltd, Malta Titan Fund, LP, SOAM Capital Partners, L.P., Terry Maltese | April 30, 2009 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.